Category: Laureates

A major step to accelerate growth and develop their technology platform manufacturing precision radiopharmaceuticals based on llama derived antibodies

Thanks to their particular envelope, the ADCs developed by Mablink Bioscience offer a superior drug-antibody ratio (DAR) and demonstrate high stability (FR)

Our 2017 laureate, a spinoff from UCLouvain, has been rewarded for its reactivity and solutions provided to the FPS Health in the context of the Covid-19 pandemic (FR)

ATB Therapeutics (our 2017 laureat) has developed a platform capable of generating innovative molecules from plants to fight cancer. A promising fundraising (FR)

Precirix, a private biotech that clinically tests radiopharmaceuticals in oncology, announces the arrival of Dr. Niva Almaula who will lead the company's global development strategy